BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8012972)

  • 61. Derivatives of butyric acid as potential anti-neoplastic agents.
    Rephaeli A; Rabizadeh E; Aviram A; Shaklai M; Ruse M; Nudelman A
    Int J Cancer; 1991 Aug; 49(1):66-72. PubMed ID: 1874573
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Potent cytodifferentiating agents related to hexamethylenebisacetamide.
    Breslow R; Jursic B; Yan ZF; Friedman E; Leng L; Ngo L; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5542-6. PubMed ID: 2062836
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line.
    Aviram A; Zimrah Y; Shaklai M; Nudelman A; Rephaeli A
    Int J Cancer; 1994 Mar; 56(6):906-9. PubMed ID: 8119779
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of butyric acid derivative with xylitol.
    Desmet G; Brazier M; Cerutti J; Chany C; Arnould-Guerin ML
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():348-51. PubMed ID: 1820907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis.
    Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An anti-cancer derivative of butyric acid (pivalyloxmethyl buterate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells.
    Kasukabe T; Rephaeli A; Honma Y
    Br J Cancer; 1997; 75(6):850-4. PubMed ID: 9062406
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Methylated oxypurines and induction of differentiation of murine erythroleukemia cells.
    Kerr SJ
    Mol Cell Biochem; 1990 Jan; 92(1):37-44. PubMed ID: 2106620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel anticancer prodrugs of butyric acid. 2.
    Nudelman A; Ruse M; Aviram A; Rabizadeh E; Shaklai M; Zimrah Y; Rephaeli A
    J Med Chem; 1992 Feb; 35(4):687-94. PubMed ID: 1542095
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Butyrate and phenylacetate as differentiating agents: practical problems and opportunities.
    Newmark HL; Young CW
    J Cell Biochem Suppl; 1995; 22():247-53. PubMed ID: 8538206
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells.
    Yoshida M; Hoshikawa Y; Koseki K; Mori K; Beppu T
    J Antibiot (Tokyo); 1990 Sep; 43(9):1101-6. PubMed ID: 2211374
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562.
    Lozzio CB; Lozzio BB; Machado EA; Fuhr JE; Lair SV; Bamberger EG
    Nature; 1979 Oct; 281(5733):709-10. PubMed ID: 298333
    [No Abstract]   [Full Text] [Related]  

  • 72. 5-Nitrofuran derivatives of fatty acid hydrazides induce differentiation in human myeloid leukaemic cell lines.
    Sur P; Chatterjee SP; Roy P; Sur B
    Cancer Lett; 1995 Jul; 94(1):27-32. PubMed ID: 7621441
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vitro intestinal bioaccessibility of alkylglycerols versus triacylglycerols as vehicles of butyric acid.
    Martín D; Morán-Valero MI; Señoráns FJ; Reglero G; Torres CF
    Lipids; 2011 Mar; 46(3):277-85. PubMed ID: 21225371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alkylformamides as inducers of tumour cell differentiation--a mini-review.
    Langdon SP; Hickman JA
    Toxicology; 1987 Mar; 43(3):239-49. PubMed ID: 3547773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Butyric monosaccharide ester-induced cell differentiation and anti-tumor activity in mice. Importance of their prolonged biological effect for clinical applications in cancer therapy.
    Pouillart P; Cerutti I; Ronco G; Villa P; Chany C
    Int J Cancer; 1991 Aug; 49(1):89-95. PubMed ID: 1874576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies.
    Pouillart PR
    Life Sci; 1998; 63(20):1739-60. PubMed ID: 9820119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hydrolysis of tributyrin by species of "Neisseria" and "Branhamella" (author's transl)].
    Riou JY; Buissière J; Guibourdenche M; Brault G; Carlier JP
    Ann Microbiol (Paris); 1981; 132(2):159-69. PubMed ID: 7235454
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Self-Assembled Nanoparticles of a Prodrug Conjugate Based on Pyrimethanil for Efficient Plant Disease Management.
    Tian Y; Huang Y; Zhang X; Tang G; Gao Y; Zhou Z; Li Y; Wang H; Yu X; Li X; Liu Y; Yan G; Wang J; Cao Y
    J Agric Food Chem; 2022 Sep; 70(38):11901-11910. PubMed ID: 36111893
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prolonged survival in erythroleukemia].
    Oliven A; Ghitis J; Rosenfeld T; Bassan H
    Harefuah; 1980 Feb; 98(3):114-5. PubMed ID: 6933132
    [No Abstract]   [Full Text] [Related]  

  • 80. Effect of Aspergillus terreus extract on neoplastic and non-neoplastic cell replication.
    Pugliese A; Vidotto V; Pollono AM; Biglino A
    J Chemother; 1994 Feb; 6(1):61-6. PubMed ID: 8071682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.